Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study.
Winnie ChuaJonathan P LawVictor R CardosoYanish PurmahGeorgiana NeculauMuhammad J Ul-QamarKalisha RussellAshley TurnerSamantha P TullFrantisek NehajPaul BradyPeter KastnerAndré ZieglerGeorgios V GkoutosDavor PavlovicCharles Joseph FerroPaulus F KirchhofLarissa FabritzPublished in: PLoS medicine (2021)
Registry IRAS ID 97753 Health Research Authority (HRA), United Kingdom.